Pfizer To Purchase NextWave For ADHD Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer is exercising its option to buy privately held NextWave Pharmaceuticals. The acquisition, which is expected to close in the fourth quarter, will give Pfizer the recently approved ADHD drug Quillivant XR.